Reduced hunger
Many GLP-1 users report feeling satisfied with smaller meals or forgetting to eat at usual times.
Hunger, fullness and cravings can shift quickly on Mounjaro, Wegovy and other GLP-1s. GLPPal helps you log and notice the patterns.
GLP-1 receptor agonists — including tirzepatide and semaglutide — work in part by affecting signals related to hunger and fullness. Many people notice reduced food noise, smaller portions, or changes in what they crave, especially in the first weeks or after a dose increase. Appetite is personal and can fluctuate day to day. Tracking does not tell you what to eat; it helps you observe how your experience evolves over time and gives you clearer notes to share with your healthcare provider if you choose to.
This tool pairs with medication-specific trackers for Mounjaro tracker, Wegovy tracker, and GLP-1 trackers hub — or open the hub to see every GLP-1 tracker.
Users often combine this with Injection Tracker and Weight Loss Tracker for a fuller weekly picture.
Many GLP-1 users report feeling satisfied with smaller meals or forgetting to eat at usual times.
Feeling full sooner during meals is commonly reported, especially after dose increases.
Some people notice less constant thinking about food, though this varies widely person to person.
Hunger may creep back toward the end of the weekly cycle for some users — tracking helps you see if that pattern applies to you.
Preferences for certain foods or textures may shift. A quick note when you notice a change builds a useful record over time.
Appetite changes are one of the most noticeable effects of GLP-1 medications. Tracking helps you understand your personal response over time and prepare for conversations with your clinician. GLPPal is for personal observation, not dietary advice.
Download on the App Store to start tracking your GLP-1 journey — injections, appetite, weight and side effects in one place.
GLPPal is designed for tracking and educational purposes only and is not medical advice.